Biotech
Trading FDA, Clinical Trial Binary Events: $ACHN $JAZZ $BMY
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Achillion Pharma (NASDAQ:ACHN) expects to receive net proceeds of approximately $50 million from a private placement that includes the sale of common stock / warrants. ACHN plans to use the proceeds to fund Phase 2 clinical trials for [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $BIIB $BNC.TO $HGSI $JAZZ $QCOR $NVS
19 August 2010 – 7:40 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Biogen Idec (NASDAQ:BIIB) announced yesterday that it made an equity investment and deal that included potential license payments up to $345M with Pittsburgh, PA based Knopp Neurosciences for KNS-760704 (dexpramipexole) (oral, neuro-protective compound), which is being developed for [...]
Continue reading...Wikinvest.com Portfolio Tracker: A Useful, Free Tool for Investors
11 August 2010 – 7:14 am PST
Comments Off
I have been using the wikinvest.com portfolio tracker software for the past few months and have found it to be a useful tool for tracking my real money Ameritrade portfolio (see left column of my website for current stats). Below is a summary of some key features for this free software tracking tool and some [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $DEPO $EXAS $JAZZ $PYMX.OB
11 August 2010 – 6:00 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… DepoMed (NASDAQ:DEPO) announced that it has reached a Special Protocol Assessment (SPA) agreement with the FDA for the design of the pivotal Phase 3 (BREEZE) clinical trial for SERADA (extended release gabapentin), which will be evaluated as a [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $VRTX $INHX $ELN $TTHI
10 August 2010 – 6:35 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Vertex Pharma (NASDAQ:VRTX) reported Phase 3 ILLUMINATE study results for telaprevir (VX-950 or TVR) that included SVR / viral cure rates of 92% (24-week treatment) and 88% (48-week treatment) for patients with hepatitis C virus (HCV) infection. VRTX [...]
Continue reading...FDA, Clinical Trial Extreme Trade Stocks: $BMOD.OB $EPCT $GNBT
9 August 2010 – 6:35 am PST
Comments Off
Below are some stocks trading at $1 per share or less with pending binary events in the form of expected FDA decisions or clinical trial results that are expected to have a major percentage impact on the underlying share prices and represent high risk / reward, speculative trading opportunities. On 6/24/10, Biomoda (OTCBB:BMOD) ($0.17, $15 [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $AMRN $DDSS $FOLD
7 August 2010 – 8:10 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Amarin Corp. (NASDAQ:AMRN) has a conference call scheduled for Tuesday 10-August at 11am (ET) and plans to provide an update on its financials and a progress update on the two ongoing pivotal Phase 3 studies (MARINE and ANCHOR) [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $PPCO $DEPO $ENDP $IRIS $AGN
6 August 2010 – 7:14 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Penwest Pharma (NASDAQ:PPCO) expects to report top-line results for a pair of ongoing Phase 2a studies by year-end 2010 with a goal of licensing A0001 (alpha-tocopherol-quinone) to a partner to complete / fund further clinical development and potential [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $AFFY $ALXA $INCY $PGNX
5 August 2010 – 11:14 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… Affymax (NASDAQ:AFFY) and partner Takeda Pharma (OTC:TKPHY) reported that further analysis is ongoing for the previously reported pivotal PEARL and EMERALD studies of HEMATIDE (long-acting anemia drug) (peg-inesatide) for the treatment of chronic renal failure patients with anemia. [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $ATRC $BIOD $CTIC
4 August 2010 – 9:00 am PST
Comments Off
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news… AtriCure (NASDAQ:ATRC) expects to file the final clinical module with the FDA for a Pre-Market Approval (PMA) submission during 1Q11 to support marketing clearance for its Isolator Synergy Bipolar Ablation System to re-establish normal heart rhythm in patients [...]
Continue reading...
20 August 2010 – 5:14 am PST
Comments Off